Sfoglia per SSD CHIM/08 - CHIMICA FARMACEUTICA
Mechanistic and Structural Insights on Difluoromethyl-1,3,4-Oxadiazole Inhibitors of HDAC6
2024 Cellupica, E; Gaiassi, A; Rocchio, I; Rovelli, G; Pomarico, R; Sandrone, G; Caprini, G; Cordella, P; Cukier, C; Fossati, G; Marchini, M; Bebel, A; Airoldi, C; Palmioli, A; Stevenazzi, A; Steinkühler, C; Vergani, B
Synthesis and Biological Characterization of TLR4 Agonists as Innovative Vaccine Adjuvants
2023 Romerio, A
DEVELOPMENT OF NEW “GENERAL PURPOSE” METHODS TO INTRODUCE FLUORINE-18 IN BIOLOGICALLY ACTIVE MOLECULES
2023 Iannone, M
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants
2023 Romerio, A; Gotri, N; Franco, A; Artusa, V; Shaik, M; Pasco, S; Atxabal, U; Matamoros-Recio, A; Minguez-Toral, M; Zalamea, J; Franconetti, A; Abrescia, N; Jimenez-Barbero, J; Anguita, J; Martin-Santamaria, S; Peri, F
NMR-based Ligand–Receptor Interaction Studies under Conventional and Unconventional Conditions
2022 Ciaramelli, C; Palmioli, A; Airoldi, C
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, in Vitro, and in Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity
2022 Palmioli, A; Mazzoni, V; De Luigi, A; Bruzzone, C; Sala, G; Colombo, L; Bazzini, C; Zoia, C; Inserra, M; Salmona, M; De Noni, I; Ferrarese, C; Diomede, L; Airoldi, C
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure
2022 Luraghi, A; Ferrandi, M; Barassi, P; Arici, M; Hsu, S; Torre, E; Ronchi, C; Romerio, A; Chang, G; Ferrari, P; Bianchi, G; Zaza, A; Rocchetti, M; Peri, F
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity
2022 Ciaramelli, C; Palmioli, A; Angotti, I; Colombo, L; De Luigi, A; Sala, G; Salmona, M; Airoldi, C
Rational drug design and synthesis of new steroid derivatives for the treatment of chronic heart failure
2021 Luraghi, A
Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin
2021 Palmioli, A; Nicolini, G; Tripodi, F; Orsato, A; Ceresa, C; Donzelli, E; Arici, M; Coccetti, P; Rocchetti, M; La Ferla, B; Airoldi, C
On-cell Saturation Transfer Difference NMR study of Bombesin binding to GRP receptor
2020 Palmioli, A; Ceresa, C; Tripodi, F; La Ferla, B; Nicolini, G; Airoldi, C
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis
2020 Facchini, F; Di Fusco, D; Barresi, S; Luraghi, A; Minotti, A; Granucci, F; Monteleone, G; Peri, F; Monteleone, I
Methacycline displays a strong efficacy in reducing toxicity in a SCA3 Caenorhabditis elegans model
2019 Amigoni, L; Airoldi, C; Natalello, A; Romeo, M; Diomede, L; Tortora, P; Regonesi, M
bioNMR-based identification of natural anti-Aβ compounds in Peucedanum ostruthium
2019 Palmioli, A; Bertuzzi, S; De Luigi, A; Colombo, L; La Ferla, B; Salmona, M; De Noni, I; Airoldi, C
Synthesis of the New Cyanine-Labeled Bacterial Lipooligosaccharides for Intracellular Imaging and in Vitro Microscopy Studies
2019 Wang, T; Cochet, F; Facchini, F; Zaffaroni, L; Serba, C; Pascal, S; Andraud, C; Sala, A; Di Lorenzo, F; Maury, O; Huser, T; Peri, F
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties
2019 Cochet, F; Facchini, F; Zaffaroni, L; Billod, J; Coelho, H; Holgado, A; Braun, H; Beyaert, R; Jerala, R; Jimenez-Barbero, J; Martin-Santamaria, S; Peri, F
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists
2018 Facchini, F; Zaffaroni, L; Minotti, A; Rapisarda, S; Calabrese, V; Forcella, M; Fusi, P; Airoldi, C; Ciaramelli, C; Billod, J; Schromm, A; Braun, H; Palmer, C; Beyaert, R; Lapenta, F; Jerala, R; Pirianov, G; Martin-Santamaria, S; Peri, F
Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108
2018 Pallach, M; Di Lorenzo, F; Facchini, F; Gully, D; Giraud, E; Peri, F; Duda, K; Molinaro, A; Silipo, A
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives
2018 Zaffaroni, L; Peri, F
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling
2018 Palmer, C; Peri, F; Neumann, F; Ahmad, F; Leake, D; Pirianov, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile